The global medical foam market is expected to grow from USD 14.06 billion in 2016 to USD 30.89 billion by 2026, at a CAGR of 8.2% from 2016 to 2026.
The key factors expected to drive the growth of the market include, the high demand for the production of sterilized medical packaging materials, growth in the aging population providing a sizeable customer base for medical foams, government funding and grants for the development of advanced medical foam products, and the increased shift from traditional to advanced wound care products in various regions.
Polyolefin: The fastest growing segment of the market, based on material type
Based on material type, the medical foam market is segmented into polyurethane, polystyrene, polyvinyl chloride, polyolefin, and others. The polyolefin segment was the fastest growing segment in the global medical foam market in 2015.
Complete report on Medical Foam Marketspread across 176 pages, profiling 18 companies and supported with 97 tables and 85 figures is now available at www.rnrmarketresearch.com/medical-foam-market-by-material-type-polyurethane-polystyrene-polyolefin-form-flexible-rigid-spray-application-medical-packaging-medical-devices-components-prosthetics-wound-care-and-region-glob-st-to-2026-market-report.html
Study on Medical Foam, has been validated through primary interviews with various industry experts globally. - Agency -.
- Agency -.
The interviews were conducted on Medical Foam with various key people such as Director Level (10%), C level (20%) and other (70%) from various key organizations.
The primary interviews were conducted worldwide covering regions such as North America (25%), Europe (33%), Asia-Pacific (25%), and Row (17%).
It also discusses the competitive strategies adopted by different market players, such as,
- The DOW Chemical Company (U.S.),
- BASF SE (Germany),
- Bayer AG (Germany),
- Sekisui Chemical Co, Ltd. (Japan),
- Huntsman Corporation (U.S.),
- Trelleborg AB (Sweden),
- Inoac Corporation (Japan),
- Recticel NV (Belgium),
- Vita (Lux III) S.à r.l. (U.K.),
- Armacell International and others
Reasons to access this report:
This report covers the following key aspects:
- The market size by 2021 and the projected growth rate.
- The key market trends.
- The key factors expected to drive the market.
- The challenges that impact market growth.
- The key players in this market.
The Asia-Pacific medical foam market is expected to be the fastest-growing market. The region was the largest market for medical foam in 2015, and has high growth potential in India, China, and Japan.
The rises in the manufacture of pharmaceutical products and medical instruments for domestic use as well as exports drive the medical foam market. The increasing demand for high-quality products, rising population, and growing end-use industries have led to innovations and developments in the industry.
For more information: